In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking Convergence of machine learning and genomics for precision oncology Nature Reviews Cancer The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on unproven peptides promoted by RFK Jr. An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News